Equine Recurrent Uveitis: Deep Welfare Guide
Equine recurrent uveitis causes repeated painful inflammation episodes leading to progressive vision loss — a chronic welfare challenge requiring intensive management.
Key Facts
- ERU is the leading cause of blindness in horses worldwide
- Repeated inflammatory episodes cause cumulative damage including cataract, retinal detachment, and lens luxation
- Appaloosas are genetically predisposed, with up to 25% affected in some studies
- Suprachoroidal cyclosporine implants in Europe significantly reduce recurrence in treated eyes
- Pain management during acute flares is critical — untreated uveitis causes severe ocular pain
Welfare Considerations
ERU causes significant chronic welfare suffering through repeated episodes of severe ocular pain and the progressive, cumulative vision loss that follows each inflammatory episode. Horses in acute uveitis flares show blepharospasm, excessive tearing, photophobia, and behavioral changes including head shyness and reluctance to enter bright light — all indicators of significant pain. Without effective management, the cumulative damage of multiple flares leads to blindness in the affected eye. Welfare management requires prompt recognition and treatment of each acute flare (topical and systemic anti-inflammatories), investigation of underlying causes including leptospirosis serology, and in Europe, consideration of cyclosporine implants to dramatically reduce recurrence frequency.
What You Can Do
- Learn to recognize early uveitis signs: increased tearing, blepharospasm, cloudiness, light avoidance
- Begin topical anti-inflammatory treatment immediately at first sign of a flare
- Discuss leptospirosis serology with your veterinarian — leptospiral ERU has specific treatment implications
- Seek referral to a veterinary ophthalmologist to discuss cyclosporine implant candidacy
- Assess vision and quality of life regularly — blind horses can be managed well with appropriate adaptations